GTHX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own GTHX shares is 126, representing 54.62% of the company's common stock.

GSA CAPITAL PARTNERS LLP, in the last quarter, reduced its stake in GTHX by -58.59% restricting it's holding to 10.77 thousand shares of worth nearly $47.00K. ADVISOR GROUP HOLDINGS, INC. also lessened -52.85% of the GTHX shares from its portfolio, reducing its holding to 10.43 thousand shares of worth $45.04K. XTX TOPCO LTD also shunned GTHX shares holding by -93.45% last quarter which brought its holding to 10.3 thousand shares worth $44.51K.

As per its latest 13F filing, ENVESTNET ASSET MANAGEMENT INC increased its stake in GTHX by 27.96% in the last quarter. The institutional holder raised its holding to 35.42 thousand shares having worth more than $153.02K. QUANTBOT TECHNOLOGIES LP also added 100% more shares of GTHX to its portfolio, raising its holding to 8.8 thousand shares of worth $38.02K. SQUAREPOINT OPS LLC also increased its GTHX shares holding by 548.39% which brought its holding to 105.16 thousand shares worth $454.27K.

The insider with the most stakes in GTHX is Bailey John E. (Jack) Jr. , President and CEO at the company. Additionally, GTHX stock is highly held by Chief Business Officer Avagliano Mark and Chief Financial Officer Umstead John W. V among others.

Company executives, directors, and other insiders own 10.92% percent of G1 Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which GTHX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include UMSTEAD JOHN W. V, MALIK RAJESH, and MURDOCK TERRY L.

There have been 0 transaction(s) during the past 6-months in which G1 Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 0 G1 Therapeutics, Inc. shares are held by insiders, which represents about 10.92% of GTHX stock.

GTHX President and CEO, Bailey John E. (Jack) Jr. holds the largest portfolio of the company's shares. GTHX shares owned by Bailey total nearly 549.67 thousand.

ENVESTNET ASSET MANAGEMENT INC is the largest institutional owner in GTHX which holds 35.42 thousand shares worth $153.02K or 0.07% of the total GTHX shares outstanding followed by GSA CAPITAL PARTNERS LLP with ownership of 10.77 thousand shares representing 0.02% of the GTHX ownership. ADVISOR GROUP HOLDINGS, INC. is the third largest stakeholder with 10.43 thousand shares or 0.02% of the ownership worth more than $45.04K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the GTHX is concerned, it is a stock which is optionable.

Number of GTHX shares short is 3.41M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 52.76M shares of GTHX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, GTHX has 39.15M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for GTHX is 1.01.